Where Do SGLT2 Inhibitors Fit in Diabetes Care?

Dr. Clifford Bailey explains how the mechanism of action differs with the new 'flozin' drugs for type 2 diabetes, and where they fit in the overall armamentarium for this disease.

Source: Medscape Pharmacists Podcast - October 15, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts